Natalia Roberto , Mireia Vazquez , Joaquim Radua , Jose Carlos Pariente , Emma Muñoz-Moreno , Carlos Laredo , Lorenzo Bracco , Tábatha Fernández , Sara Martín-Parra , Anabel Martínez-Aran , Jose Sánchez-Moreno , Pilar Saiz , Miguel Ruiz-Veguilla , Roger Borras , Alba Toll , Matilde Elices , Paolo Brambilla , Philippe Courtet , Víctor Perez-Solà , Eduard Vieta , Iria Grande
{"title":"改善自杀企图者功能的安全干预（STRONG）：二级预防研究。研究原理和研究方案。","authors":"Natalia Roberto , Mireia Vazquez , Joaquim Radua , Jose Carlos Pariente , Emma Muñoz-Moreno , Carlos Laredo , Lorenzo Bracco , Tábatha Fernández , Sara Martín-Parra , Anabel Martínez-Aran , Jose Sánchez-Moreno , Pilar Saiz , Miguel Ruiz-Veguilla , Roger Borras , Alba Toll , Matilde Elices , Paolo Brambilla , Philippe Courtet , Víctor Perez-Solà , Eduard Vieta , Iria Grande","doi":"10.1016/j.sjpmh.2023.05.001","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Suicide is one of the most largely preventable causes of death worldwide. The aim of the STRONG study is to assess the effectiveness of a specific intervention (an extended Safety Planning Intervention) called <em>iFightDepression-SURVIVE</em> (iFD-S) in suicidal attempters by changes in psychosocial functioning. As secondary outcomes, quality of life, cognitive performance, clinical state and neuroimaging correlates will be considered.</div></div><div><h3>Objective</h3><div>To describe the rationale and design of the STRONG study, an extension of the SURVIVE study, a national multicenter cohort about on prevention in suicidal attempters.</div></div><div><h3>Methods</h3><div>The STRONG study is a two-year clinical trial. A total sample of 60 patients will be randomly allocated to two arms: a group will receive a iFD-S and treatment as usual (TAU) (<em>n</em> <!-->=<!--> <!-->30 treatment group), while another group will exclusively receive TAU (<em>n</em> <!-->=<!--> <!-->30 control group). There will be three study points: baseline; 3-month; and 6-month follow-up assessments, all of which will include rater-blinded evaluation of psychosocial functioning, quality of life, clinical state, cognitive performance and neuroimaging acquisition.</div></div><div><h3>Results</h3><div>It is expected to obtain data on the efficacy of iFD-S in patients who have committed a suicide attempt.</div></div><div><h3>Conclusion</h3><div>Results will provide insight into the effectiveness of IFD-S in suicidal attempters with respect to improvements in psychosocial functioning, quality of life, cognition, and neuroimaging correlates.</div></div><div><h3>Clinical trials ID</h3><div><span><span>NCT05655390</span><svg><path></path></svg></span>.</div></div>","PeriodicalId":101179,"journal":{"name":"Spanish Journal of Psychiatry and Mental Health","volume":"19 1","pages":"Pages 66-72"},"PeriodicalIF":2.6000,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Safety intervention for improving functioning in suicidal attempters (STRONG): A secondary prevention study. Study rationale and research protocol\",\"authors\":\"Natalia Roberto , Mireia Vazquez , Joaquim Radua , Jose Carlos Pariente , Emma Muñoz-Moreno , Carlos Laredo , Lorenzo Bracco , Tábatha Fernández , Sara Martín-Parra , Anabel Martínez-Aran , Jose Sánchez-Moreno , Pilar Saiz , Miguel Ruiz-Veguilla , Roger Borras , Alba Toll , Matilde Elices , Paolo Brambilla , Philippe Courtet , Víctor Perez-Solà , Eduard Vieta , Iria Grande\",\"doi\":\"10.1016/j.sjpmh.2023.05.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Suicide is one of the most largely preventable causes of death worldwide. The aim of the STRONG study is to assess the effectiveness of a specific intervention (an extended Safety Planning Intervention) called <em>iFightDepression-SURVIVE</em> (iFD-S) in suicidal attempters by changes in psychosocial functioning. As secondary outcomes, quality of life, cognitive performance, clinical state and neuroimaging correlates will be considered.</div></div><div><h3>Objective</h3><div>To describe the rationale and design of the STRONG study, an extension of the SURVIVE study, a national multicenter cohort about on prevention in suicidal attempters.</div></div><div><h3>Methods</h3><div>The STRONG study is a two-year clinical trial. A total sample of 60 patients will be randomly allocated to two arms: a group will receive a iFD-S and treatment as usual (TAU) (<em>n</em> <!-->=<!--> <!-->30 treatment group), while another group will exclusively receive TAU (<em>n</em> <!-->=<!--> <!-->30 control group). There will be three study points: baseline; 3-month; and 6-month follow-up assessments, all of which will include rater-blinded evaluation of psychosocial functioning, quality of life, clinical state, cognitive performance and neuroimaging acquisition.</div></div><div><h3>Results</h3><div>It is expected to obtain data on the efficacy of iFD-S in patients who have committed a suicide attempt.</div></div><div><h3>Conclusion</h3><div>Results will provide insight into the effectiveness of IFD-S in suicidal attempters with respect to improvements in psychosocial functioning, quality of life, cognition, and neuroimaging correlates.</div></div><div><h3>Clinical trials ID</h3><div><span><span>NCT05655390</span><svg><path></path></svg></span>.</div></div>\",\"PeriodicalId\":101179,\"journal\":{\"name\":\"Spanish Journal of Psychiatry and Mental Health\",\"volume\":\"19 1\",\"pages\":\"Pages 66-72\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2026-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Spanish Journal of Psychiatry and Mental Health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2950285323000017\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/9/7 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"0\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Spanish Journal of Psychiatry and Mental Health","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2950285323000017","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/9/7 0:00:00","PubModel":"Epub","JCR":"0","JCRName":"PSYCHIATRY","Score":null,"Total":0}
Safety intervention for improving functioning in suicidal attempters (STRONG): A secondary prevention study. Study rationale and research protocol
Background
Suicide is one of the most largely preventable causes of death worldwide. The aim of the STRONG study is to assess the effectiveness of a specific intervention (an extended Safety Planning Intervention) called iFightDepression-SURVIVE (iFD-S) in suicidal attempters by changes in psychosocial functioning. As secondary outcomes, quality of life, cognitive performance, clinical state and neuroimaging correlates will be considered.
Objective
To describe the rationale and design of the STRONG study, an extension of the SURVIVE study, a national multicenter cohort about on prevention in suicidal attempters.
Methods
The STRONG study is a two-year clinical trial. A total sample of 60 patients will be randomly allocated to two arms: a group will receive a iFD-S and treatment as usual (TAU) (n = 30 treatment group), while another group will exclusively receive TAU (n = 30 control group). There will be three study points: baseline; 3-month; and 6-month follow-up assessments, all of which will include rater-blinded evaluation of psychosocial functioning, quality of life, clinical state, cognitive performance and neuroimaging acquisition.
Results
It is expected to obtain data on the efficacy of iFD-S in patients who have committed a suicide attempt.
Conclusion
Results will provide insight into the effectiveness of IFD-S in suicidal attempters with respect to improvements in psychosocial functioning, quality of life, cognition, and neuroimaging correlates.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
